Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (9): 566-567.
DOI: 10.19803/j.1672-8629.2019.09.09
Previous Articles Next Articles
WU Qingyun1, PAN Yuhua2, LIANG Huaban3, YE Zhiming3, LAO Haiyan2,*
Received:2019-03-04
Revised:2019-10-21
Online:2019-09-20
Published:2019-10-21
CLC Number:
WU Qingyun, PAN Yuhua, LIANG Huaban, YE Zhiming, LAO Haiyan. One Case of Numbness of Extremities Induced by Cyclosporine Soft Capsules[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 566-567.
| [1] 程凯, 贾萍, 徐埏, 等. 72例环孢素A所致不良反应文献分析[J].中国药业, 2010, 19(1): 36-37. [2] 常馨予, 郭桂明, 刘洋. 等. 药物相互作用致环孢素不良反应分析及药学监护[J]. 药学实践杂志, 2018,36(4):365-368. [3] Batinić D, Milošević D, Filipović-Grčić B, et al.Neurotoxicity of cyclosporine A in children with steroid-resistant nephrotic syndrome: is cytotoxic edema really an unfavorable predictor of permanent neurological damage?[J]. Wien Klin Wochenschr, 2017, 129(15-16): 579-582. [4] 曲彩红, 苏向阳.伏立康唑致环孢素血药浓度升高相关癫痫样发作[J].药物不良反应杂志, 2010, 12(5): 354-356. [5] 丁春雷, 孙健姿, 张熠, 等. 环孢素浓度异常升高致高尿酸血症1例[J].中国药物警戒, 2011, 8(3):190. [6] da Silva J B, de Melo Lima M H, Secoli S R. Influence of cyclosporine on the occurrence of nephrotoxicity after allogeneichematopoietic stem cell transplantation: a systematic review[J]. Rev Bras Hematol Hemoter, 2014,36(5):363-368. [7] 叶晓兰, 唐崑. 一例环孢素引起外周神经系统损害的病例分析[J]. 上海医药, 2017, 38(5): 57-59. [8] 曾湘豫, 秦斌, 曹国颖, 等. 环孢菌素A血浓度监测对神经系统自身免疫性疾病治疗的意义[J]. 中国神经免疫学和神经病学杂志, 2001, 8(3): 153-156. [9] Yanagimachi M, Naruto T, Tanoshima R, et al.Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation[J]. Clin Transplant, 2010, 24(6): 855-861. [10] Crettol S, Venetz J P, Fontana M, et al.CYP3A7,CYP3A5,CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients[J]. Ther Drug Monit, 2008, 30(6): 689-699. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
